Levels of tyrosine phosphorylation and actin-enriched lamellipodia on fibronectin were also more prominent than in cells on collagen I. Studies using pharmacological inhibitors or transient transfections revealed that the preferential TGF-β1 effects in cells on fibronectin required c-Src family kinase activity. These observations suggest that a specific cross-talk between TGF-β1 and fibronectin-binding integrin signal pathways leads to the activation of cSrc/Rac1/actin-organization, leading to changes in cell cycle regulator levels in hepatoma cells. Therefore, this study represents another mechanism to regulate cell cycle regulators when integrin signaling is collaborative with TGF-β1 pathways.
INTRODUCTION
Cell proliferation is a tightly controlled and ordered process including multiple checkpoints responsible for the regulation of abnormal cell cycle progression. Transition between cell cycle phases is regulated by biochemically-coordinated actions of cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors (CKIs), all of which can in turn be modulated by signal transduction initiated from extracellular growth factors [1] . So far, the G1 to S phase transition through the restriction (R) point has been shown to be regulated by mitogenic reagents, intact cytoskeletal network, as well as cell adhesion [2] [3] [4] [5] [6] .
Cell adhesion is mediated by the engagement of cells to ECMs through integrins [5, 7] .
Integrins are a heterodimeric cell adhesion receptor consisting of an α subunit and a β subunit.
Approximately two dozen combinations from 18 α and 8 β subunits are known to assemble.
These interactions are well-known to regulate diverse biological functions of cells including cell adhesion, spreading, proliferation, migration, survival, gene transcription, and cell cycle progression [5, 8, 9] . Integrin-mediated signaling include direct signaling transduced by integrins engaging with ECMs leading to downstream intracellular signaling molecules, and collaborative signaling where integrins co-signal with other receptor-mediated signaling pathways, such as receptor tyrosine kinases (RTKs) and G-protein coupled receptors (GPCRs).
Both integrin-mediated direct signaling and collaborative (indirect) signaling modulate cell adhesion and spreading, which are important events in the mitogenic response of cells to extracellular stimuli including growth factors [4, 5, 10, 11] .
On the other hand, integrin-mediated cell adhesion is well-known to activate small (RhoA) GTPase family members, such as RhoA, Rac1, and CDC42, which regulate the actin cytoskeletal organization and lead to stress fiber/focal adhesions turnover, lamellipodia, and filopodia formation, respectively [12] . Interestingly, activated GTPases are shown to regulate cell cycle progression, by modulating either transcriptionally or translationally the level of the G1 phase cyclin, cyclin D, or by inducing the timing of cyclin D expression, during G1 [4, [13] [14] [15] [16] [17] . It may be interesting to know how actin reorganization via activation of these GTPases may regulate expression of cell cycle regulators, and how such a regulatory relationship depends on signaling cross-talk between integrins and TGF-β1 pathways.
Transforming growth factor-β1 (TGF-β1) is a multifunctional cytokine that inhibits epithelial cell growth and stimulates growth of fibroblasts as well, by binding to a heterodimeric receptor consisting of both type 1 (TβR1) and type 2 (TβRII) serine/threonine kinase receptors. On binding TGF-β1, the TβRII transphosphorylates and activates TβRI.
Activation of the receptor complex propagates intracellular signal transduction involving SMAD proteins, which regulate numerous developmental and homeostatic processes by regulating gene expression [18] [19] [20] . Recently, TGF-β1-mediated but SMAD-independent signaling pathways have also been observed in various cell culture systems that involve numerous intracellular signaling molecules including Erk1/2, JNKs, and p38 MAPK, c-Src, Rho proteins, FAK, and Ras [21, 22] . Similar to RTKs or GPCRs, TGF-β1 receptor mediated signal pathway is also collaborative with integrin signaling. It was previously reported that treating mammary epithelial cells with TGF-β1 resulted in an epithelialmesenchymal transdifferentiation (EMT), which required both a functional integrin β1 and active p38 MAPK [23] .
We observed that Hep3B cells treated with TGF-β1 resulted in lamellipodia formation and increased cyclins D and E. Integrin-mediated cell adhesion signaling also appeared to affect lamellipodia formation through actin reorganization and cyclin levels. Therefore, we tried to answer how the integrin-and TGF-β1-mediated signal cross-talk lead to lamellipodia formation and increased expressions of cell cycle regulators. This study revealed that TGF-β1 induced lamellipodia formation through activation of c-Src and subsequently Rac1 in cells replated on fibronectin, but not on collagen I. The different TGF-β1 effects on fibronectin correlated with increased expression of cyclins E and A and suppression of p27 Kip1 CKI, in hepatoma cells. These indicate another putative cell cycle regulation mechanism in which cell cycle regulators are modulated through c-Src/Rac1/actin reorganization when TGF-β1 pathways encounter specific integrin signaling activity.
MATERIALS AND METHODS
Cells: Hep3B and Hur7 hepatocarcinoma cells were purchased from ATCC and grown in 37 o C and 5% CO 2 in RPMI-60 culture media containing 10% fatal bovine serum.
Cell lysate preparation and Western Blot: After cells in normal cultures were treated without or with TGF-β1 for 48 hr, or after cells were replated and incubated on collagen I or fibronectin in the absence of serum for 15 hr, cell lysates were prepared as described in previous studies [24, 25] . Briefly, cells trypsinized were incubated in suspension within serum free media plus 1% BSA (replating media) for 1 hr before replating on indicated ECMs Flow cytometry: Flow cytometric measurements of integrin subtypes on cells were performed as previously described [24] . For the studies of TGF-β1 effects on integrin expression levels, Hep3B cells were treated with TGF-β1 (5 ng/ml) in a serum containing normal condition for 48 hr before harvesting for flow cytometric measurements. The raw data were analyzed by using WinMDI software program (version 2.7, Scripps Institute, San Diego, CA).
Phase-contrast imaging: Cells replated on the indicated substrates and treated with TGF-β1
were imaged by using a phase-contrast microscope.
Rac1 in vitro pull down assay: Rac1 activity in the cells under various conditions was examined via a pull-down assay by using an activation specific probe GST-PAK1 (76-150), as described previously [17] . Lysates from diverse treatment conditions were prepared as explained above. 
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RESULTS
While studying possible cross-talk between integrins and TGF-β1 signaling pathways, we have observed that hepatocarcinoma Hep3B cells showed lamellipodia formation by treatment with TGF-β1 in a serum-containing normal culture conditions. The lamellipodia formation was correlated with Rac1 activation ( Figure 1A ). Interestingly, we also found that the TGF-β1 treatment resulted in increased levels of cyclins D1 and E, although cyclins A and B1 were reduced. However, the activity of Erk1/2, which is important for inducing cyclin D in G1 phase, was unexpectedly slightly reduced ( Figure 1B ). Therefore, it is possible that alternative regulatory signaling pathways, rather than Erks-mediated cyclin D1 induction, may modulate cell cycle regulators in this system, and that TGF-β1 treatment may trigger such pathways. To test this possibility, the mechanisms underlying the TGF-β1-mediated lamellipodia formation and alterations in cyclin expression were explored.
Effects of TGF-β1 on integrin expression
Integrin-mediated cell adhesion is well-known to activate the RhoA GTPase family including Rac1. Therefore, we wondered if the TGF-β1 effects were mediated by a crosstalk mechanism between the TGF-β1 and integrin signaling pathways, and if the effects are integrin signaling-dependent. First, we analyzed integrin expression levels before and after TGF-β1 treatment to cells in serum-containing culture media to see which integrin subtype might be involved in response to TGF-β1. When integrin subunits (such as α1, α2, α3, α4, α5, α6, α v β 3 , α v β 5 , β 1 , and β 4 ) were examined in the absence or presence of TGF-β1 for 48
hr, the level of α2 integrin subunit, a major collagen I receptor, was increased by TGF-β1 treatment. However, the α5 subunit, a typical fibronectin receptor, was reduced ( Figure 2 ).
Other major β1-conjugating integrin subunits including another major fibronectin-binding α4 subunit were not altered ( Figure 2 , data not shown).
Different TGF-β1 effects on Rac1 activation and cell cyclin regulation on fibronectin
Next, we tried to examine if the TGF-β1 effects involve specific integrin signaling pathways, because lamellipodia formation and Rac1 activation usually occur through integrinmediated cell adhesion signaling. We hypothesized that the signaling cross-talk between TGF-β1-and specific integrin type-mediated signaling pathways may lead to the Rac1 activation (thus lamellipodia formation) and increased cyclin expression. To test it, cells were replated either on collagen I or fibronectin, and at the same time TGF-β1 was added to the replating media. After a 15 hr incubation cell lysates were prepared. The incubation time was decided from preliminary experiments in which lamellipodia formation was examined over various time points from 2 to 15 h in the presence of TGF-β1 (data not shown). Figure 4B ). c-Src activities were also parallely regulated by the ECM types and TGF-β1 treatment. The TGF-β1 effects on cyclins E and A expression were also dependent on cSrc family kinase inhibition ( Figure 4C ). Interestingly, the p27 Kip1 , but not other CKIs, levels were inversely regulated, being consistent with the TGF-β1 effects, which were also dependent on the PP2 treatment ( Figure 4C ). However, inhibition of Erk1/2 or p38 MAPK did not abolish the TGF-β1 effects, indicating their no involvements (data not shown).
Preferential formation of lamellipodia and focal adhesion dependent on c-Src family kinase activity
Integrin-mediated signaling modulates lamellipodia and focal adhesion formation through actin reorganization [12] . Therefore, we tried to examine if c-Src family kinase signaling in cells on fibronectin may underlie preferential lamellipodia and focal adhesion formation even upon TGF-β1 treatment, compared to cells on collagen I. Immunofluorescence images for tyrosine phosphorylated proteins in cells on either collagen I or fibronectin in the absence or presence of TGF-β1 treatment were compared to one another. In both untreated and TGF-β1-treated cells, phospho-tyrosine staining was more prominent in focal adhesions at cell boundaries in cells on fibronectin than on collagen I ( Figure 5A ). Furthermore, the phosphotyrosine staining was also inhibited by cytochalasin D treatment, which disrupts actin filament (data not shown). Again the preferential staining of phospho-tyrosine proteins at focal adhesions was dependent on c-Src family kinase inhibition ( Figure 5A ). In addition, TGF-β1-treated cells on fibronectin spread more with peripheral actin enrichment, with forming lamellipodia, than cells on collagen I ( Figure 5B ). Furthermore, the lamellipodia formation on fibronectin was inhibited by PP2, but not PP3, treatment ( Figure 5B ). Therefore, it is likely that TGF-β1 treatment caused different effects depending on integrin subtypes, as observed by more prominent lamellipodia formation and phospho-tyrosine staining at focal adhesions in cells on fibronectin, but not significantly on collagen I.
c-Src activity-dependent TGF-β1 effects
We next examined whether increased c-Src activity might turn on the fibronectin Figure 6A, lanes 1 and 2) . Therefore, the TGF-β1 effects indeed depend on c-Src activity.
The TGF-β1 effects in Hur7 hepatoma cells
Next we determined whether the TGF-β1 effects can also be found in another hepatoma cell line, Hur7. As shown in figure 7 , basal and TGF-β1-mediated activation of Rac1 and cSrc and expression levels of cyclins E and A were prominent in cells on fibronectin, compared to cells on collagen I. They were also dependent on c-Src family kinase activity, like Hep3B cells. Furthermore, the expression level of p27 Kip1 CKI and hypophosphorylation of retinoblastoma protein (pRb) were inversely correlated with the levels of cyclins, and dependent on c-Src family kinase activity ( Figure 7B ). These results indicate that G1 and S phase cyclins were up-regulated by activation of c-Src and Rac1 when TGF-β1 was treated to hepatoma cells on fibronectin. Therefore, this study represents another pathway of cSrc/Rac1/actin reorganization to regulate cell cycle progression.
DISCUSSION
In this study, we showed that TGF-β1 activated Rac1 via c-Src family kinase, and that the TGF-β1 effects correlated with enhanced expression of cyclins E and A levels and suppression of p27 Kip1 CKI in hepatoma cells replated on fibronectin, but not on collagen I, leading to another cell cycle regulation mechanism upon TGF-β1 treatment in hepatoma cells.
This current study clearly showed that TGF-β1 treatment during normal culture with serum-containing media resulted in up-regulated expression levels of cyclins D1 and E ( Figure 1C) , with an eventual cyclin B1 reduction. Being consistent with these observations, it was also previously shown that TGF-β1 treatment to Hep3B cells showed sustained expression of cyclin E and an eventual G2 arrest [26] . Additionally in this study, however, cells were replated on specific ECMs in the presence of TGF-β1 but in the absence of serum were analyzed. When thereby TGF-β1 pathways cross-talk with specific integrin subtypedependent signaling, cells on fibronectin showed increased levels of cyclins E and A, compared to cells on collagen I, while cyclin D1 levels were unaffected ( Figure 3 ). This discrepancy between serum-containing condition and no-serum containing replated-conditions as for the cyclin A expression might be presumably due to increased significance of integrin and ECM-mediated signaling in the replated conditions. That is, cells replated on fibronectin could have signaling activities initiated only from TGF-β1 and fibronectinintegrin interaction mediated signaling, whereas TGF-β1-treated cells within serumcontaining media might have diverse signaling activities mediated by serum components.
The key effectors downstream of integrin receptors include c-Src and Rac1 and etc, leading to the activation of diverse intracellular signaling and actin reorganization (e.g., lamellipodia formation) and the regulation of cell cycle regulators [4, 5, 8, 9, 10, 11, 12] . Furthermore, in this study, the increased expression levels of cyclins in the presence of TGF-β1 correlated with c-Src activation and lamellipodia formation in cells replated on only specific ECM substrates. These results indicate specificity in signal cross-talks between integrin-and TGF-β1-mediated pathways, resulting in differential signaling activities depending on ECMs where cells are on. It is well known that not only integrin-mediated signaling but also mitogenic signaling activities is required for cell cycle progression through regulation of cyclin levels, because normal epithelial cells do not divide in suspension where no cell adhesion signaling is available [4, 27] .
It was previously shown that TGF-β1 could activate Rac1, when cells were treated with TGF-β1 for a relatively shorter time of 2.5.min or 60 min [28, 29] . In this current study, Rac1 activation was shown 15 hr after TGF-β1 treatment, when lamellipodia formation and S phase cell accumulation was significant in cells on fibronectin. In another previous study, the activity of CDC42 and RhoA by TGF-β1 showed two peaks, one for around 5 ~ 15 min and the other around 6 ~ 12 hr after a TGF-β1 treatment [30] . We show here that GTPases including Rac1 is also downstream effector of TGF-β1 signaling after prolong TGF-β1 treatment in hepatoma cells.
On the other hand, it was also previously shown that TGF-β1 influenced c-Src activity either negatively or positively depending on the cell type and/or the nature of its treatment.
HaCaT human keratinocytes, MDCK kidney epithelial cells, and Mahalavu hepatoma cells, showed increases in c-Src activity [31, 32] , when TGF-β1 was treated for 15 min, unlike this current study where cells were treated for 15 hr. Meanwhile v-Src transformed rat fibroblasts and HepG2 hepatoma and PC3 human prostate carcinoma cells showed reduced cSrc activity and protein abundance with TGF-β1 treatment [32, 33] . Therefore, the effects of TGF-β1 on c-Src may also be dependent on the cell types and/or signal contexts under which TGF-β1 treatment occurred.
In this study, c-Src appears to be upstream of Rac1, cyclins, and p27 Kip1 CKI, since its pharmacological inhibition of c-Src family kinase abolished the TGF-β1 effects on Rac1 activation, lamellipodia formation, increased cyclins E and A levels, and a decreased p27 It is interesting to note that the TGF-β1 treatment decreased the integrin α5 subunit (a typical fibronectin receptor), and increased integrin α2 subunit (a major collagen I receptor), while there were no alterations in other types tested, such as another major fibronectinbinding integrin α4 as well as other several β1-binding subtypes (Figure 2 , data not shown).
However, basal and TGF-β1-mediated activations of c-Src family kinase and Rac1 and increases in cyclins E and A expression in cells on fibronectin were preferentially and significantly higher than those in cells on collagen I. In addition, integrin-mediated signaling monitored by phospho-tyrosine proteins or actin immunostainings was more prominent in cells on fibronectin than in cells on collagen I. Such prominent signaling may presumably lead to the preferential TGF-β1 effects on fibronectin, even with decreased levels of integrin α5. An explanation of this paradox may involve signaling efficiency with a lower threshold in TGF-β1-treated cells on fibronectin, although it remains to be explored.
That is, even a reduced level (but not to null) of integrin α5 could be enough for efficient transduction (via a lower threshold) of signal cross-talks with TGF-β1 pathway toward c-Src and Rac1, whereas signal cross-talks via integrin α2 or collagen receptors could not presumably due to a higher threshold. In addition to this study, there is previous evidence that signaling activity upon growth factor treatment in cells on fibronectin (presumably via the α5 integrin subunit) is more efficient than that in cells on collagen I or laminin (presumably via the α2 integrin subunit) [17, 24, 25] . On the other hand, it may also be possible that TGF-β1 caused a signaling shift from by integrin α5-mediated fibronectin binding to by adhesion through other fibronectin-binding integrin types, although another major fibronectinbinding integrin α4 was not significantly regulated by the TGF-β1 treatment (Figure 2 ).
Taken together, this study showed that TGF-β1 treatment on hepatoma cells resulted in preferential Rac1-mediated lamellipodia formation, expression of cyclins E and A, and suppression of p27 Kip1 CKI level in cells on fibronectin, but not on collagen I. All of these TGF-β1 effects were dependent on c-Src activity. These observations may indicate that another putative mechanism involving c-Src/Rac1/actin organization to regulate cell cycle regulators, when TGF-β1 pathway encountered a specific integrin-mediated signal pathway in hepatoma cells. Data show histograms for integrin α2 (top), α5 (middle), or α4 (bottom) subunits.
LEGENDS TO FIGURES
Histograms for a negative control (C, without primary antibody), untreated (Un) or treated with TGF-β1 (T) were included. 
